DOCSLIB.ORG

14-3-3Ζ–TRAF5 Axis Governs Interleukin-17A Signaling

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

14-3-3ζ–TRAF5 axis governs interleukin-17A signaling Jenna McGowana,1, Cara Petera,1, Joshua Kima, Sonam Poplib, Brent Veermana, Jessica Saul-McBethc, Heather Contic, Shondra M. Pruett-Millerd, Saurabh Chattopadhyayb, and Ritu Chakravartia,2 aDepartment of Physiology & Pharmacology, College of Medicine & Life Sciences, University of Toledo, Toledo, OH 43614; bDepartment of Medical Microbiology & Immunology, College of Medicine & Life Sciences, University of Toledo, Toledo, OH 43614; cDepartment of Biological Sciences, College of Natural Sciences & Mathematics, University of Toledo, Toledo, OH 43614; and dDepartment of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN 38105 Edited by Vishva M. Dixit, Genentech, San Francisco, CA, and approved August 31, 2020 (received for review April 27, 2020) IL-17A is a therapeutic target in many autoimmune diseases. Most of target genes, such as IL6 and IL8 (18). On the other hand, the nonhematopoietic cells express IL-17A receptors and respond to recruitment of TRAF2 and TRAF5 participates in the stabiliza- extracellular IL-17A by inducing proinflammatory cytokines. The IL- tion of mRNA transcripts of CXCL1 and CXCL5 (19). The 17A signal transduction triggers two broad, TRAF6- and TRAF5- TRAF5/TRAF2-dependent mRNA stabilization pathway is inde- dependent, intracellular signaling pathways to produce representative pendent of the presence of TRAF6 (19); however, the role of cytokines (IL-6) and chemokines (CXCL-1), respectively. Our limited TRAF5/TRAF2 in the transcriptional pathway remains unknown. understanding of the cross-talk between these two branches has In addition, IL-17A activates MAP kinases, including ERK, p38, generated a crucial gap of knowledge, leading to therapeutics and JNK, that play essential roles in autoimmune diseases (20, indiscriminately blocking IL-17A and global inhibition of its target 21). Although several regulators of each transcriptional and genes. In previous work, we discovered an elevated expression of nontranscriptional branch are known (17), there is a knowledge 14-3-3 proteins in inflammatory aortic disease, a rare human au- gap in understanding of cross-talk between the two branches. toimmune disorder with increased levels of IL-17A. Here we report Identifying regulators that promote one branch over the other will that 14-3-3ζ is essential for IL-17 signaling by differentially regu- provide critical information to design targeted therapeutics. lating the signal-induced IL-6 and CXCL-1. Using genetically manip- To address this, we examined the role of 14-3-3ζ in the IL-17A ulated human and mouse cells, and ex vivo and in vivo rat models, signaling. 14-3-3ζ is one of the seven members of 14-3-3 family we uncovered a function of 14-3-3ζ. As a part of the molecular that interacts with 0.6% of the cellular proteome and performs a mechanism, we show that 14-3-3ζ interacts with several TRAF pro- range of context-dependent functions, including signaling IMMUNOLOGY AND INFLAMMATION teins; in particular, its interaction with TRAF5 and TRAF6 is increased (22–24). The 14-3-3ζ regulates the signal transduction of GM- in the presence of IL-17A. In contrast to TRAF6, we found TRAF5 to CSF, IL-3, IL-5, STAT3, Toll-like receptor (TLR)3, and AMPK, be an endogenous suppressor of IL-17A–induced IL-6 production, an among others (25–29). Additionally, it supports the production effect countered by 14-3-3ζ. Furthermore, we observed that 14-3-3ζ of several cytokines, such as IL-13, IFN-γ, and IL-17A (30, 31). – interaction with TRAF proteins is required for the IL-17A induced IL- We previously identified increased 14-3-3 protein levels in the ζ 6 levels. Together, our results show that 14-3-3 is an essential com- aortic tissues of patients with large-vessel vasculitis (32). Large- ponent of IL-17A signaling and IL-6 production, an effect that is vessel vasculitis is a presumed autoimmune disease with in- suppressed by TRAF5. To the best of our knowledge, this report creased infiltration of Th1 and Th17 cells in the affected artery, ζ – of the 14-3-3 -TRAF5 axis, which differentially regulates IL-17A induced resulting in increased levels of IL-17A and IL-6 (33–35). In the IL-6 and CXCL-1 production, is unique. Significance 14-3-3ζ | IL-17A | TRAF Blocking IL-17A signaling is an attractive therapy in treating nterleukin-17A (IL-17A) is an inflammatory cytokine that is autoimmune diseases. Current IL-17A blockers target both Iassociated with autoimmune diseases and host-defense (1, 2). signaling branches, leading to inhibition of TRAF6-based IL-6 Increased IL-17A level in the sera of patients with rheumatoid – production, and TRAF5-based CXCL-1 production. Global sup- arthritis, psoriasis, and lupus, is well documented (3 5). The IL- pression of both branches is of concern due to the critical role 17A blocking therapy has been clinically successful to manage – IL-17A plays in the host-defense mechanisms. Our study shows psoriasis, but not other diseases (6 8). Current IL-17A blockers that 14-3-3ζ is necessary for IL-17A–stimulated IL-6 production. lack specificity and compromise the host-defense mechanisms (9, We also found that 14-3-3ζ represses TRAF5-mediated sup- 10). There is a need to design inhibitors that can target specific pression of IL-17A–stimulated IL-6 induction. Taken together, outcomes of IL-17A signaling. To achieve such a goal, we need our results show a unique cross-talk between two branches via to improve the understanding of IL-17A signal transduction and the 14-3-3ζ–TRAF5 axis that regulates the IL-17A signaling identify the regulatory mechanisms for each set of genes. output. These foundational results can lead to the design of a The most common targets of IL-17A signaling include NF- κ – unique inhibitor targeting a specific branch of IL-17A signaling B dependent cytokines, chemokines, antimicrobial peptides and obtaining the desired output. (AMP), and matrix metalloproteases (11, 12). IL-17A plays a significant role in up-regulating the production of inflammatory Author contributions: S.P., S.C., and R.C. designed research; J.M., C.P., J.K., S.P., B.V., cytokines via either transcriptional (gene expression) or post- J.S.-M., H.C., and R.C. performed research; B.V., S.M.P.-M., and R.C. contributed new transcriptional (mRNA stabilization) branches (5, 13). IL-17A reagents/analytic tools; J.M., C.P., J.K., S.P., J.S.-M., H.C., S.C., and R.C. analyzed data; signal transduction occurs via IL-17 receptors consisting of the IL- and J.M., S.C., and R.C. wrote the paper. 17RA and IL-17RC subunits (14). While IL-17RA is ubiquitously The authors declare no competing interest. expressed, IL-17RC has limited expression to nonhematopoietic This article is a PNAS Direct Submission. epithelial and mesenchymal cells (15, 16). IL-17A binding to its Published under the PNAS license. receptor results in the recruitment of the cytosolic signaling 1J.M. and C.P. contributed equally to this work. complex consisting of Act1 and several TRAF proteins [see review 2To whom correspondence may be addressed. Email: [email protected]. for further details (17)]. Recruitment of TRAF6 results in the This article contains supporting information online at https://www.pnas.org/lookup/suppl/ activation of downstream molecules, including TAK1, eventually doi:10.1073/pnas.2008214117/-/DCSupplemental. leading to translocation of NF-κB to the nucleus and transcription www.pnas.org/cgi/doi/10.1073/pnas.2008214117 PNAS Latest Articles | 1of10 Downloaded by guest on September 29, 2021 present study, we identified a requirement of intracellular 14-3- drives Renilla luciferase by a NF-κB promoter, and a firefly lu- 3ζ in IL-17A signal transduction. We used 14-3-3ζ knockout ciferase driven by thymidine kinase promoter in the 14-3-3ζ (KO) murine fibroblasts and human epithelial cells to examine knockdown (KD) HeLa cells, and measured luciferase activity the role of 14-3-3ζ in IL-17A signaling. Our results show that 14- after the stimulation with IL-17A (39). The ablation of 14-3-3ζ 3-3ζ is essential for IL6, IL8, and Defb3 production in IL-17A resulted in significant suppression of the IL-17A–induced NF-κB signaling; however, it has an opposite effect on CXCL1 pro- activity in a luciferase assay (lanes 2 and 4, Fig. 2A). The com- duction. To validate our finding, we engineered 14-3-3ζ global KO plementation with HA-tagged 14-3-3ζ resulted in a substantial Lewis rats using CRISPR/Cas9 and subjected them to IL-17A rescue of NF-κB activity in 14-3-3ζKD cells (lanes 4 and 6, treatment, a technique successfully used to determine the Act1 Fig. 2A). Encouraged by these results, we focused on a specific role in IL-17A signal transduction (36). Similar to cells, the 14-3- stage of NF-κB activation, the nuclear translocation of the p65 3ζKO rats show a decrease in the IL-17A–stimulated IL-6 pro- subunit of NF-κB, in IL-17A–stimulated cells. IL-17A treatment of duction but an increase in CXCL-1 level. In the absence of 14-3- ARPE-19 cells resulted in the nuclear translocation of p65, which 3ζ, IL-17A–stimulated ERK phosphorylation (pERK) and p65 was inhibited in the 14-3-3ζKO ARPE-19 cells, analyzed by confocal translocation are decreased. The 14-3-3ζ interacts with TRAFs via microscopy (Fig. 2B). Similarly, we observed IL-17A–stimulated two of its TRAF-binding motifs (TBMs), particularly TRAF5, increase in nuclear p65+ cells in WT MEFs but not in 14-3-3ζKO which bound more strongly in the presence of IL-17A.
Recommended publications
  • RT² Profiler PCR Array (384-Well Format) Human Apoptosis 384HT

    RT² Profiler PCR Array (384-Well Format) Human Apoptosis 384HT

    RT² Profiler PCR Array (384-Well Format) Human Apoptosis 384HT Cat. no. 330231 PAHS-3012ZE For pathway expression analysis Format For use with the following real-time cyclers RT² Profiler PCR Array, Applied Biosystems® models 7900HT (384-well block), Format E ViiA™ 7 (384-well block); Bio-Rad CFX384™ RT² Profiler PCR Array, Roche® LightCycler® 480 (384-well block) Format G Description The Human Apoptosis RT² Profiler PCR Array profiles the expression of 370 key genes involved in apoptosis, or programmed cell death. The array includes the TNF ligands and their receptors; members of the bcl-2 family, BIR (baculoviral IAP repeat) domain proteins, CARD domain (caspase recruitment domain) proteins, death domain proteins, TRAF (TNF receptor-associated factor) domain proteins and caspases. These 370 genes are also grouped by their functional contribution to apoptosis, either anti-apoptosis or induction of apoptosis. Using real-time PCR, you can easily and reliably analyze expression of a focused panel of genes related to apoptosis with this array. For further details, consult the RT² Profiler PCR Array Handbook. Sample & Assay Technologies Shipping and storage RT² Profiler PCR Arrays in formats E and G are shipped at ambient temperature, on dry ice, or blue ice packs depending on destination and accompanying products. For long term storage, keep plates at –20°C. Note: Ensure that you have the correct RT² Profiler PCR Array format for your real-time cycler (see table above). Note: Open the package and store the products appropriately immediately
  • Megakaryopoiesis in Dengue Virus Infected K562 Cell Promotes Viral Replication Which Inhibits 2 Endomitosis and Accumulation of ROS Associated with Differentiation

    Megakaryopoiesis in Dengue Virus Infected K562 Cell Promotes Viral Replication Which Inhibits 2 Endomitosis and Accumulation of ROS Associated with Differentiation

    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.25.172544; this version posted June 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title: Megakaryopoiesis in Dengue virus infected K562 cell promotes viral replication which inhibits 2 endomitosis and accumulation of ROS associated with differentiation 3 Jaskaran Kaur *1, Yogita Rawat *1, Vikas Sood 2, Deepak Rathore1, Shrikant K. Kumar1, Niraj K. Kumar1 4 and Sankar Bhattacharyya1 5 1 Translational Health Science and Technology Institute, NCR Biotech Science Cluster, PO Box# 4, 6 Faridabad-Gurgaon expressway, Faridabad, Haryana-121001, India 7 2 Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard (Hamdard 8 University) Hamdard Nagar, New Delhi - 110062, India 9 10 *Equal contribution 11 Email for correspondence: [email protected] 12 13 14 Keywords: Dengue virus replication, Megakaryopoiesis, Reactive oxygen species, Endomitosis 15 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.25.172544; this version posted June 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 16 Abstract: In the human host blood Monocytes and bone marrow Megakaryocytes are implicated as major 17 sites supporting high replication. The human K562 cell line supports DENV replication and represent 18 Megakaryocyte-Erythrocyte progenitors (MEP), replicating features of in vivo Megakaryopoiesis upon 19 stimulation with Phorbol esters. In this article, we report results that indicate the mutual influence of 20 Megakaryopoiesis and DENV replication on each other, through comparison of PMA-induced 21 differentiation of either mock-infected or DENV-infected K562 cells.
  • Expression of the Tumor Necrosis Factor Receptor-Associated Factors

    Expression of the Tumor Necrosis Factor Receptor-Associated Factors

    Expression of the Tumor Necrosis Factor Receptor- Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells Keith F. Izban, M.D., Melek Ergin, M.D, Robert L. Martinez, B.A., HT(ASCP), Serhan Alkan, M.D. Department of Pathology, Loyola University Medical Center, Maywood, Illinois the HD cell lines. Although KMH2 showed weak Tumor necrosis factor receptor–associated factors expression, the remaining HD cell lines also lacked (TRAFs) are a recently established group of proteins TRAF5 protein. These data demonstrate that consti- involved in the intracellular signal transduction of tutive expression of TRAF1 and TRAF2 is a charac- several members of the tumor necrosis factor recep- teristic feature of HRS cells from both patient and tor (TNFR) superfamily. Recently, specific members cell line specimens. Furthermore, with the excep- of the TRAF family have been implicated in promot- tion of TRAF1 expression, HRS cells from the three ing cell survival as well as activation of the tran- HD cell lines showed similar TRAF protein expres- ␬ scription factor NF- B. We investigated the consti- sion patterns. Overall, these findings demonstrate tutive expression of TRAF1 and TRAF2 in Hodgkin the expression of several TRAF proteins in HD. Sig- and Reed–Sternberg (HRS) cells from archived nificantly, the altered regulation of selective TRAF paraffin-embedded tissues obtained from 21 pa- proteins may reflect HRS cell response to stimula- tients diagnosed with classical Hodgkin’s disease tion from the microenvironment and potentially (HD). In a selective portion of cases, examination of contribute both to apoptosis resistance and cell HRS cells for Epstein-Barr virus (EBV)–encoded maintenance of HRS cells.
  • Evolutionary Divergence and Functions of the Human Interleukin (IL) Gene Family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W

    Evolutionary Divergence and Functions of the Human Interleukin (IL) Gene Family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W

    UPDATE ON GENE COMPLETIONS AND ANNOTATIONS Evolutionary divergence and functions of the human interleukin (IL) gene family Chad Brocker,1 David Thompson,2 Akiko Matsumoto,1 Daniel W. Nebert3* and Vasilis Vasiliou1 1Molecular Toxicology and Environmental Health Sciences Program, Department of Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO 80045, USA 2Department of Clinical Pharmacy, University of Colorado Denver, Aurora, CO 80045, USA 3Department of Environmental Health and Center for Environmental Genetics (CEG), University of Cincinnati Medical Center, Cincinnati, OH 45267–0056, USA *Correspondence to: Tel: þ1 513 821 4664; Fax: þ1 513 558 0925; E-mail: [email protected]; [email protected] Date received (in revised form): 22nd September 2010 Abstract Cytokines play a very important role in nearly all aspects of inflammation and immunity. The term ‘interleukin’ (IL) has been used to describe a group of cytokines with complex immunomodulatory functions — including cell proliferation, maturation, migration and adhesion. These cytokines also play an important role in immune cell differentiation and activation. Determining the exact function of a particular cytokine is complicated by the influence of the producing cell type, the responding cell type and the phase of the immune response. ILs can also have pro- and anti-inflammatory effects, further complicating their characterisation. These molecules are under constant pressure to evolve due to continual competition between the host’s immune system and infecting organisms; as such, ILs have undergone significant evolution. This has resulted in little amino acid conservation between orthologous proteins, which further complicates the gene family organisation. Within the literature there are a number of overlapping nomenclature and classification systems derived from biological function, receptor-binding properties and originating cell type.
  • Supplementary Table 8. Cpcp PPI Network Details for Significantly Changed Proteins, As Identified in 3.2, Underlying Each of the Five Functional Domains

    Supplementary Table 8. Cpcp PPI Network Details for Significantly Changed Proteins, As Identified in 3.2, Underlying Each of the Five Functional Domains

    Supplementary Table 8. cPCP PPI network details for significantly changed proteins, as identified in 3.2, underlying each of the five functional domains. The network nodes represent each significant protein, followed by the list of interactors. Note that identifiers were converted to gene names to facilitate PPI database queries. Functional Domain Node Interactors Development and Park7 Rack1 differentiation Kcnma1 Atp6v1a Ywhae Ywhaz Pgls Hsd3b7 Development and Prdx6 Ncoa3 differentiation Pla2g4a Sufu Ncf2 Gstp1 Grin2b Ywhae Pgls Hsd3b7 Development and Atp1a2 Kcnma1 differentiation Vamp2 Development and Cntn1 Prnp differentiation Ywhaz Clstn1 Dlg4 App Ywhae Ywhab Development and Rac1 Pak1 differentiation Cdc42 Rhoa Dlg4 Ctnnb1 Mapk9 Mapk8 Pik3cb Sod1 Rrad Epb41l2 Nono Ltbp1 Evi5 Rbm39 Aplp2 Smurf2 Grin1 Grin2b Xiap Chn2 Cav1 Cybb Pgls Ywhae Development and Hbb-b1 Atp5b differentiation Hba Kcnma1 Got1 Aldoa Ywhaz Pgls Hsd3b4 Hsd3b7 Ywhae Development and Myh6 Mybpc3 differentiation Prkce Ywhae Development and Amph Capn2 differentiation Ap2a2 Dnm1 Dnm3 Dnm2 Atp6v1a Ywhab Development and Dnm3 Bin1 differentiation Amph Pacsin1 Grb2 Ywhae Bsn Development and Eef2 Ywhaz differentiation Rpgrip1l Atp6v1a Nphp1 Iqcb1 Ezh2 Ywhae Ywhab Pgls Hsd3b7 Hsd3b4 Development and Gnai1 Dlg4 differentiation Development and Gnao1 Dlg4 differentiation Vamp2 App Ywhae Ywhab Development and Psmd3 Rpgrip1l differentiation Psmd4 Hmga2 Development and Thy1 Syp differentiation Atp6v1a App Ywhae Ywhaz Ywhab Hsd3b7 Hsd3b4 Development and Tubb2a Ywhaz differentiation Nphp4
  • IL-1/IL-3 Gene Therapy of Non-Small Cell Lung Cancer (NSCLC) in Rats Using ‘Cracked’ Adenoproducer Cells

    IL-1/IL-3 Gene Therapy of Non-Small Cell Lung Cancer (NSCLC) in Rats Using ‘Cracked’ Adenoproducer Cells

    Gene Therapy (1998) 5, 778–788 1998 Stockton Press All rights reserved 0969-7128/98 $12.00 http://www.stockton-press.co.uk/gt IL-1/IL-3 gene therapy of non-small cell lung cancer (NSCLC) in rats using ‘cracked’ adenoproducer cells MC Esandi1,2, GD van Someren1, A Bout3, AH Mulder4, DW van Bekkum3, D Valerio1,3 and JL Noteboom1,5 1Section Gene Therapy, Department of Molecular Cell Biology, Leiden University; 3IntroGene BV, Leiden; and 4Pathologisch Laboratorium, Dordrecht, The Netherlands Cytokine gene therapy was studied in established L42 tumour responses. These were due to local release of cyto- tumours in syngeneic rats. L42 is a transplantable non- kines, not to systemic effects. Growth retardation also immunogenic non-small cell lung cancer (NSCLC). Genes occurred in contralateral tumours which were not injected. coding for human interleukin-1␣ and for rat interleukin-3␤ When rats carrying established tumours were vaccinated were transferred by injecting producer cells of recombinant with lysates of tumours collected during treatment with adenovirus vectors into the tumour in attempts to achieve ‘cracked’ producer cells, significant tumour growth retar- high concentrations of the cytokines inside the tumor with- dation was obtained. We speculate that both cytokines, if out systemic toxicity. Limited tumour growth delay was produced at sufficiently high concentrations in tumours, obtained with viable producer cells. For logistic reasons induce inflammation which in turn initiates an immune stocks of pooled frozen producer cells allowed intensive response against tumours growing at a distant site. These treatment of groups of tumour bearing rats. The cells were findings seem to justify further exploration of IL-1 and IL-3 lysed by thawing before administration.
  • Characterization of Genes in the CFTR-Mediated Innate Immune Response

    Characterization of Genes in the CFTR-Mediated Innate Immune Response

    The University of Maine DigitalCommons@UMaine Honors College 5-2012 Characterization of Genes in the CFTR-Mediated Innate Immune Response Eric Peterman Follow this and additional works at: https://digitalcommons.library.umaine.edu/honors Part of the Cell and Developmental Biology Commons, and the Molecular Biology Commons Recommended Citation Peterman, Eric, "Characterization of Genes in the CFTR-Mediated Innate Immune Response" (2012). Honors College. 71. https://digitalcommons.library.umaine.edu/honors/71 This Honors Thesis is brought to you for free and open access by DigitalCommons@UMaine. It has been accepted for inclusion in Honors College by an authorized administrator of DigitalCommons@UMaine. For more information, please contact [email protected]. CHARACTERIZATION OF GENES IN THE CFTR-MEDIATED INNATE IMMUNE RESPONSE by Eric Peterman A Thesis Submitted in Partial Fulfillment of the Requirements for a Degree with Honors (Biochemistry, Molecular and Cellular Biology) The Honors College University of Maine May 2012 Advisory Committee: Carol Kim, Professor, Molecular & Biomedical Sciences Robert Gundersen, Associate Professor, Molecular & Biomedical Sciences John Singer, Professor, Molecular & Biomedical Sciences Julie Gosse, Assistant Professor, Molecular & Biomedical Sciences Keith Hutchison, Professor, Molecular & Biomedical Sciences Mark Haggerty, Lecturer, Rezendes Preceptor for Civic Engagement Abstract: Recently, the Kim Lab has shown that the cystic fibrosis transmembrane conductance regulator (cftr) gene is responsible for mediating resistance to Pseudomonas aeruginosa in a zebrafish infection model. Using the Gene Expression Omnibus, an NCBI functional genomics data repository, it was determined that Smad3, a transcription factor in the TGF-β signaling pathway, is upregulated in the presence of P. aeruginosa. It was found that in our zebrafish model, the Smad3 paralogs Smad3a and Smad3b are upregulated following microinjection of a cftr antisense morpholino oligomer.
  • Evolution of Gremlin 2 in Cetartiodactyl Mammals: Gene Loss Coincides with Lack of Upper Jaw Incisors in Ruminants

    Evolution of Gremlin 2 in Cetartiodactyl Mammals: Gene Loss Coincides with Lack of Upper Jaw Incisors in Ruminants

    Evolution of gremlin 2 in cetartiodactyl mammals: gene loss coincides with lack of upper jaw incisors in ruminants Juan C. Opazo1, Kattina Zavala1, Paola Krall2 and Rodrigo A. Arias3 1 Instituto de Ciencias Ambientales y Evolutivas, Universidad Austral de Chile, Valdivia, Chile 2 Unidad de Nefrología, Universidad Austral de Chile, Valdivia, Chile 3 Instituto de Producción Animal, Universidad Austral de Chile, Valdivia, Chile ABSTRACT Understanding the processes that give rise to genomic variability in extant species is an active area of research within evolutionary biology. With the availability of whole genome sequences, it is possible to quantify different forms of variability such as variation in gene copy number, which has been described as an important source of genetic variability and in consequence of phenotypic variability. Most of the research on this topic has been focused on understanding the biological significance of gene duplication, and less attention has been given to the evolutionary role of gene loss. Gremlin 2 is a member of the DAN gene family and plays a significant role in tooth development by blocking the ligand-signaling pathway of BMP2 and BMP4. The goal of this study was to investigate the evolutionary history of gremlin 2 in cetartiodactyl mammals, a group that possesses highly divergent teeth morphology. Results from our analyses indicate that gremlin 2 has experienced a mixture of gene loss, gene duplication, and rate acceleration. Although the last common ancestor of cetartiodactyls possessed a single gene copy, pigs and camels are the only cetartiodactyl groups that have retained gremlin 2. According to the phyletic distribution of this gene and synteny analyses, we propose that gremlin 2 was lost in the common ancestor of ruminants and cetaceans between 56.3 and 63.5 million years ago as a product of a chromosomal rearrangement.
  • 14-3-3Ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer And

    14-3-3Ζ, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer And

    Author Manuscript Published OnlineFirst on August 17, 2012; DOI: 10.1158/1078-0432.CCR-12-0281 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 14-3-3ζ, a novel androgen-responsive gene, is upregulated in prostate cancer and promotes prostate cancer cell proliferation and survival Taro Murata1,2 Ϯ, Ken-ichi Takayama1,3,4 Ϯ, Tomohiko Urano1,3,4, Tetsuya Fujimura2, Daisaku Ashikari1,5, Daisuke Obinata1,5, Kuniko Horie-Inoue4, Satoru Takahashi5, Yasuyoshi Ouchi3, Yukio Homma2, Satoshi Inoue1,3,4 Ϯ: These authors contributed equally to this work. 1 Department of Anti-Aging Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 2 Department of Urology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 3 Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan, 4 Division of Gene Regulation and Signal Transduction, Research Center for Genomic Medicine, Saitama Medical University, Saitama, Japan, 5 Department of Urology, School of Medicine, Nihon University, Tokyo, Japan Running Title: Role of 14-3-3ζ in prostate cancer Key Words: Androgen; prostate cancer; 14-3-3 protein; androgen receptor Corresponding Author: Satoshi Inoue, Department of Anti-Aging Medicine, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan. Phone: 81-3-5800-8834; Fax: 81-3-5800-9126; E-mail: [email protected]. 1 Downloaded from clincancerres.aacrjournals.org on September 28, 2021. © 2012 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 17, 2012; DOI: 10.1158/1078-0432.CCR-12-0281 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
  • TRAF6, a Molecular Bridge Spanning Adaptive Immunity, Innate Immunity and Osteoimmunology Hao Wu1* and Joseph R

    TRAF6, a Molecular Bridge Spanning Adaptive Immunity, Innate Immunity and Osteoimmunology Hao Wu1* and Joseph R

    Review articles TRAF6, a molecular bridge spanning adaptive immunity, innate immunity and osteoimmunology Hao Wu1* and Joseph R. Arron2 Summary receptor/Toll-like receptor (IL-1R/TLR) superfamily. Gene Tumor necrosis factor (TNF) receptor associated factor targeting experiments have identified several indispen- 6 (TRAF6) is a crucial signaling molecule regulating a sable physiological functions of TRAF6, and structural diverse array of physiological processes, including and biochemical studies have revealed the potential adaptive immunity, innate immunity, bone metabolism mechanisms of its action. By virtue of its many signaling and the development of several tissues including lymph roles, TRAF6 represents an important target in the regu- nodes, mammary glands, skin and the central nervous lation of many disease processes, including immunity, system. It is a member of a group of six closely related inflammation and osteoporosis. BioEssays 25:1096– TRAF proteins, which serve as adapter molecules, coupl- 1105, 2003. ß 2003 Wiley Periodicals, Inc. ing the TNF receptor (TNFR) superfamily to intracellular signaling events. Among the TRAF proteins, TRAF6 is unique in that, in addition to mediating TNFR family Introduction signaling, it is also essential for signaling downstream of The tumor necrosis factor (TNF) receptor associated factors an unrelated family of receptors, the interleukin-1 (IL-1) (TRAFs) were first identified as two intracellular proteins, TRAF1 and TRAF2, associated with TNF-R2,(1) a member of 1Department of Biochemistry, Weill Medical College of Cornell the TNF receptor (TNFR) superfamily. There are currently six University, New York. mammalian TRAFs (TRAF1-6), which have emerged as 2Tri-Institutional MD-PhD Program, Weill Medical College of Cornell important proximal signal transducers for the TNFR super- University, New York.
  • High Levels of Soluble Herpes Virus Entry Mediator in Sera of Patients with Allergic and Autoimmune Diseases

    High Levels of Soluble Herpes Virus Entry Mediator in Sera of Patients with Allergic and Autoimmune Diseases

    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 35, No. 6, 501-508, December 2003 High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases Hyo Won Jung1, Su Jin La1, Ji Young Kim2 neutrophils and dendritic cells. In three-way MLR, Suk Kyeung Heo1, Ju Yang Kim1, Sa Wang3 mAb 122 and 139 were agonists and mAb 108 had Kack Kyun Kim4, Ki Man Lee5, Hong Rae Cho6 blocking activity. An ELISA was developed to detect Hyeon Woo Lee1, Byungsuk Kwon1 sHVEM in patient sera. sHVEM levels were elevated 1 1,7,8 in sera of patients with allergic asthma, atopic Byung Sam Kim and Byoung Se Kwon dermatitis and rheumatoid arthritis. The mAbs dis- 1 cussed here may be useful for studies of the role The Immunomodulation Research Center and of HVEM in immune responses. Detection of soluble Department of Biological Sciences HVEM might have diagnostic and prognostic value University of Ulsan, Ulsan 680-749, Korea in certain immunological disorders. 2The Immunomics Inc. Ulsan 680-749, Korea Keywords: asthma; atopic; autoimmune diseases; der- 3Department of Microbiology and Immunology matitis; inflammation mediators; rheumatoid arthritis; Indiana University School of Medicine tumor necrosis factor Indianapolis, IN 46202, USA 4Department of Oral Microbiology College of Dentistry, Seoul National University Seoul 110-744, Korea Introduction 5Department of Internal Medicine Members of the tumor necrosis factor receptor Ulsan University Hospital, University of Ulsan (TNFR) superfamily share a similar architecture of Ulsan 682-714, Korea their extracellular domain; this consists of a series of 6Department of Surgery cysteine-rich segments containing 30-40 amino acids Ulsan University Hospital, University of Ulsan with six cysteines in each segment (Mallett et al., Ulsan 682-714, Korea 7 1991).
  • Traf5 Is Differentially Expressed in High-Grade Serous Ovarian Cancer And

    Traf5 Is Differentially Expressed in High-Grade Serous Ovarian Cancer And

    1 Traf5 is differentially expressed in high-grade serous ovarian cancer and based on patient survival. 2 3 Shahan Mamoor1 4 [email protected] East Islip, NY 11730 5 High-grade serous ovarian cancer (HGSC) is the most common type of the most lethal 6 gynecologic malignancy (1). To identify genes whose expression was specifically perturbed in HGSC, we used published microarray data (2, 3) to compare the global gene expression 7 profiles of primary HGSC tumors to normal ovarian tissue. We found that the TNF receptor 8 associated factor 5 (TRAF5) (4, 5) was among the genes most differentially expressed in HGSC tumors relative to the normal ovary. In a separate dataset from patients enrolled in the ICON7 9 trial (6), the Traf5 gene was among those most differentially expressed when comparing HGSC tumor gene expression based on patient survival outcomes. Traf5 may be relevant to the 10 biology of high-grade serous ovarian cancers. 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Keywords: ovarian cancer, high-grade serous ovarian cancer, HGSC, targeted therapeutics in 28 ovarian cancer, systems biology of ovarian cancer. 1 OF 13 1 High-grade serous ovarian cancer (HGSC) is the most prevalent type of the most lethal 2 gynecologic malignancy: ovarian cancer (1, 7, 8). The five-year survival rate for women 3 diagnosed with high-grade serous ovarian cancer is between 30-40% and has not changed 4 significantly in decades (7, 8). Understanding how the gene expression of tumors differs from 5 the organ from which it is derived can provide insight into the mechanisms by which cancers 6 are initiated and maintained.